Himsnab Bulgaria AD Crecimiento futuro
Future controles de criterios 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Himsnab Bulgaria AD.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Real Estate | 60.3% |
Tasa de crecimiento de los ingresos | n/a |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | None |
Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Himsnab Bulgaria AD's (BUL:CHSB) Business Is Yet to Catch Up With Its Share Price
Apr 07We're Not Counting On Himsnab Bulgaria AD (BUL:58E) To Sustain Its Statutory Profitability
Feb 12Could Mixed Fundamentals Be The Reason For Himsnab Bulgaria AD's (BUL:58E) Unexciting Performance On The Stock Market?
Jan 17If You Had Bought Himsnab Bulgaria AD (BUL:58E) Shares Five Years Ago You'd Have Earned 39% Returns
Dec 16Himsnab Bulgaria AD (BUL:58E) Has A Pretty Healthy Balance Sheet
Nov 24En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Himsnab Bulgaria AD no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.
Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2023 | 62 | 9 | 7 | 7 | N/A |
9/30/2023 | 104 | 6 | 9 | 9 | N/A |
6/30/2023 | 98 | 7 | 8 | 8 | N/A |
3/31/2023 | 91 | 6 | 9 | 9 | N/A |
12/31/2022 | 39 | 5 | 7 | 7 | N/A |
9/30/2022 | 57 | 11 | 3 | 3 | N/A |
6/30/2022 | 34 | 5 | 1 | 1 | N/A |
3/31/2022 | 32 | 4 | -1 | -1 | N/A |
12/31/2021 | 31 | 4 | 1 | 1 | N/A |
9/30/2021 | 9 | 2 | 1 | 1 | N/A |
6/30/2021 | 29 | 4 | 4 | 4 | N/A |
3/31/2021 | 27 | 4 | 4 | 4 | N/A |
12/31/2020 | 25 | 4 | 4 | 4 | N/A |
9/30/2020 | 26 | 4 | 3 | 3 | N/A |
6/30/2020 | 27 | 4 | 2 | 2 | N/A |
3/31/2020 | 28 | 4 | 4 | 4 | N/A |
12/31/2019 | 27 | 4 | 4 | 4 | N/A |
9/30/2019 | 22 | 4 | 7 | 7 | N/A |
6/30/2019 | 20 | 5 | 7 | 7 | N/A |
3/31/2019 | 19 | 5 | 5 | 5 | N/A |
12/31/2018 | 19 | 4 | 6 | 6 | N/A |
9/30/2018 | 21 | -11 | 10 | 10 | N/A |
6/30/2018 | 22 | -8 | 4 | 4 | N/A |
3/31/2018 | 20 | -7 | 5 | 5 | N/A |
12/31/2017 | 21 | 1 | 1 | 1 | N/A |
9/30/2017 | 19 | 13 | N/A | -14 | N/A |
6/30/2017 | 20 | 12 | N/A | -1 | N/A |
3/31/2017 | 21 | 13 | N/A | -3 | N/A |
12/31/2016 | 19 | 5 | N/A | -3 | N/A |
9/30/2016 | 16 | 2 | N/A | -1 | N/A |
6/30/2016 | 12 | 0 | N/A | -4 | N/A |
3/31/2016 | 7 | 5 | N/A | -5 | N/A |
12/31/2015 | 7 | 5 | N/A | -4 | N/A |
9/30/2015 | 6 | 10 | N/A | 1 | N/A |
6/30/2015 | 6 | 10 | N/A | -2 | N/A |
3/31/2015 | 6 | 2 | N/A | 0 | N/A |
12/31/2014 | 6 | 1 | N/A | 1 | N/A |
9/30/2014 | 6 | 5 | N/A | 3 | N/A |
6/30/2014 | 5 | 5 | N/A | 6 | N/A |
3/31/2014 | 4 | 4 | N/A | 5 | N/A |
12/31/2013 | 3 | 4 | N/A | 5 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Insufficient data to determine if CHSB's forecast earnings growth is above the savings rate (3%).
Beneficios vs. Mercado: Insufficient data to determine if CHSB's earnings are forecast to grow faster than the BG market
Beneficios de alto crecimiento: Insufficient data to determine if CHSB's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: Insufficient data to determine if CHSB's revenue is forecast to grow faster than the BG market.
Ingresos de alto crecimiento: Insufficient data to determine if CHSB's revenue is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if CHSB's Return on Equity is forecast to be high in 3 years time